000			01546nam a22002057a 4500
005			20240426155649.0
008			210325b usudoa|| |||| 00| 0 eng d
020			_a9789814774529
040			_aB-IKIAM
041			_aeng
082			_a571.96
245			_aInmune Aspects of Biopharmaceuticals and Nanomedicines _cRaj Bawa; János Szebeni; Thomas J. Webster; Gerald F. Audette
260			_aUSA _bPan Stanford Publishing _c2018
300			_a994 p. _c22 cm.
505			_aCurrent Immune Aspects of Biologics and Nanodrugs: An Overview - Immunological Issues with Medicines of Nano Size: The Price of Dimension Paradox - Immunotherapy and Vaccines - Site-Specific Antibody Conjugation for ADC and Beyond - Current Understanding of Interactions between Nanoparticles and the Immune System - Auto-antibodies as Biomarkers for Disease Diagnosis - The Acceleated Blood Clearance Phenomenon of PEGylated Nanocarriers - Anti-PEG Immunity Against PEGylated Therapeutics - Complement Activation: Challenges to Nanomedicine Development - Intravenous Immunoglobulin at the Borderline of Nanomedicines and Biologicals: Antithrombogenic Effect via Complement Attenuation - Lessons Learned from the Porcine CARPA Model: Constant and Variable Responses to Different Nanomedicines and Administration Protocols - Rodent Models of Complement Activation-Related Pseudoallergy: Inducers, Symptoms, Inhibitors and Reaction Mechanisms
650		0	_aImmune
650		0	_aNanomedicines
650		0	_aBiopharmaceuticals
942			_2ddc _aB-IKIAM _b25-3-2021 _cBK _zbv
999			_c2104 _d2104